Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

BIT:1ELX - Euronext Milan - US5184391044 - Common Stock - Currency: EUR

74  +0.8 (+1.09%)

Fundamental Rating

3

1ELX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 12 industry peers in the Personal Care Products industry. 1ELX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, 1ELX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 1ELX was profitable.
In the past year 1ELX had a positive cash flow from operations.
1ELX had positive earnings in each of the past 5 years.
1ELX had a positive operating cash flow in each of the past 5 years.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of -4.38%, 1ELX is doing worse than 91.67% of the companies in the same industry.
With a Return On Equity value of -20.05%, 1ELX is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 5.60%, 1ELX is doing worse than 75.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1ELX is below the industry average of 11.81%.
Industry RankSector Rank
ROA -4.38%
ROE -20.05%
ROIC 5.6%
ROA(3y)5.84%
ROA(5y)6.89%
ROE(3y)22.7%
ROE(5y)26.57%
ROIC(3y)9.14%
ROIC(5y)9.86%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

1ELX's Profit Margin has declined in the last couple of years.
1ELX has a Operating Margin of 9.03%. This is in the lower half of the industry: 1ELX underperforms 66.67% of its industry peers.
1ELX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 73.85%, 1ELX is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of 1ELX has remained more or less at the same level.
Industry RankSector Rank
OM 9.03%
PM (TTM) N/A
GM 73.85%
OM growth 3Y-18.75%
OM growth 5Y-10.71%
PM growth 3Y-47.93%
PM growth 5Y-26.95%
GM growth 3Y-2.09%
GM growth 5Y-1.48%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

1ELX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, 1ELX has more shares outstanding
1ELX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1ELX has a worse debt to assets ratio.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

1ELX has an Altman-Z score of 3.15. This indicates that 1ELX is financially healthy and has little risk of bankruptcy at the moment.
1ELX's Altman-Z score of 3.15 is in line compared to the rest of the industry. 1ELX outperforms 50.00% of its industry peers.
1ELX has a debt to FCF ratio of 7.70. This is a slightly negative value and a sign of low solvency as 1ELX would need 7.70 years to pay back of all of its debts.
With a Debt to FCF ratio value of 7.70, 1ELX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.68 is on the high side and indicates that 1ELX has dependencies on debt financing.
1ELX's Debt to Equity ratio of 1.68 is on the low side compared to the rest of the industry. 1ELX is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF 7.7
Altman-Z 3.15
ROIC/WACC0.73
WACC7.66%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.41 indicates that 1ELX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.41, 1ELX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.02 indicates that 1ELX should not have too much problems paying its short term obligations.
1ELX's Quick ratio of 1.02 is fine compared to the rest of the industry. 1ELX outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.02
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

1ELX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.99%.
1ELX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.41% yearly.
1ELX shows a decrease in Revenue. In the last year, the revenue decreased by -3.76%.
Measured over the past years, 1ELX shows a small growth in Revenue. The Revenue has been growing by 0.98% on average per year.
EPS 1Y (TTM)0.99%
EPS 3Y-26.13%
EPS 5Y-13.41%
EPS Q2Q%-32.99%
Revenue 1Y (TTM)-3.76%
Revenue growth 3Y-1.26%
Revenue growth 5Y0.98%
Sales Q2Q%-9.9%

3.2 Future

The Earnings Per Share is expected to grow by 12.92% on average over the next years. This is quite good.
1ELX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.11% yearly.
EPS Next Y-41.46%
EPS Next 2Y-6.25%
EPS Next 3Y4.87%
EPS Next 5Y12.92%
Revenue Next Year-8.12%
Revenue Next 2Y-3.22%
Revenue Next 3Y-0.75%
Revenue Next 5Y2.11%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 41.81 indicates a quite expensive valuation of 1ELX.
Compared to the rest of the industry, the Price/Earnings ratio of 1ELX indicates a slightly more expensive valuation: 1ELX is more expensive than 75.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of 1ELX to the average of the S&P500 Index (27.48), we can say 1ELX is valued expensively.
Based on the Price/Forward Earnings ratio of 37.49, the valuation of 1ELX can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ELX indicates a rather expensive valuation: 1ELX more expensive than 83.33% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of 1ELX to the average of the S&P500 Index (36.52), we can say 1ELX is valued inline with the index average.
Industry RankSector Rank
PE 41.81
Fwd PE 37.49
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ELX is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, 1ELX is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 32.52
EV/EBITDA 16.39
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.25%
EPS Next 3Y4.87%

3

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 1.52%.
Compared to an average industry Dividend Yield of 2.29, 1ELX is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 2.34, 1ELX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.52%

5.2 History

The dividend of 1ELX is nicely growing with an annual growth rate of 9.59%!
Dividend Growth(5Y)9.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1ELX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of 1ELX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-83.7%
EPS Next 2Y-6.25%
EPS Next 3Y4.87%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (7/17/2025, 7:00:00 PM)

74

+0.8 (+1.09%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)08-20 2025-08-20/amc
Inst Owners94.12%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap26.62B
Analysts67.22
Price Target59.24 (-19.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.52%
Yearly Dividend2.26
Dividend Growth(5Y)9.59%
DP-83.7%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)93.44%
Min EPS beat(2)87.87%
Max EPS beat(2)99.01%
EPS beat(4)4
Avg EPS beat(4)91.1%
Min EPS beat(4)43.76%
Max EPS beat(4)133.75%
EPS beat(8)8
Avg EPS beat(8)120.03%
EPS beat(12)11
Avg EPS beat(12)82.71%
EPS beat(16)15
Avg EPS beat(16)66.99%
Revenue beat(2)0
Avg Revenue beat(2)-2.01%
Min Revenue beat(2)-2.01%
Max Revenue beat(2)-2.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)-1.43%
Revenue beat(8)1
Avg Revenue beat(8)-1.71%
Revenue beat(12)2
Avg Revenue beat(12)-1.65%
Revenue beat(16)4
Avg Revenue beat(16)-1.52%
PT rev (1m)-15%
PT rev (3m)-18.19%
EPS NQ rev (1m)-70.5%
EPS NQ rev (3m)-71.41%
EPS NY rev (1m)5.68%
EPS NY rev (3m)6.09%
Revenue NQ rev (1m)-5.13%
Revenue NQ rev (3m)-5.13%
Revenue NY rev (1m)-1.29%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 41.81
Fwd PE 37.49
P/S 2.08
P/FCF 32.52
P/OCF 19.76
P/B 7.09
P/tB N/A
EV/EBITDA 16.39
EPS(TTM)1.77
EY2.39%
EPS(NY)1.97
Fwd EY2.67%
FCF(TTM)2.28
FCFY3.08%
OCF(TTM)3.75
OCFY5.06%
SpS35.5
BVpS10.43
TBVpS-4.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.38%
ROE -20.05%
ROCE 8.95%
ROIC 5.6%
ROICexc 6.8%
ROICexgc 13.75%
OM 9.03%
PM (TTM) N/A
GM 73.85%
FCFM 6.41%
ROA(3y)5.84%
ROA(5y)6.89%
ROE(3y)22.7%
ROE(5y)26.57%
ROIC(3y)9.14%
ROIC(5y)9.86%
ROICexc(3y)12.1%
ROICexc(5y)13.99%
ROICexgc(3y)27.91%
ROICexgc(5y)31.23%
ROCE(3y)14.59%
ROCE(5y)15.74%
ROICexcg growth 3Y-21.07%
ROICexcg growth 5Y-22.32%
ROICexc growth 3Y-21.66%
ROICexc growth 5Y-23.4%
OM growth 3Y-18.75%
OM growth 5Y-10.71%
PM growth 3Y-47.93%
PM growth 5Y-26.95%
GM growth 3Y-2.09%
GM growth 5Y-1.48%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF 7.7
Debt/EBITDA 3.37
Cap/Depr 73.73%
Cap/Sales 4.14%
Interest Coverage 3.73
Cash Conversion 72.06%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.02
Altman-Z 3.15
F-Score5
WACC7.66%
ROIC/WACC0.73
Cap/Depr(3y)232.17%
Cap/Depr(5y)179.27%
Cap/Sales(3y)10.8%
Cap/Sales(5y)8.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.99%
EPS 3Y-26.13%
EPS 5Y-13.41%
EPS Q2Q%-32.99%
EPS Next Y-41.46%
EPS Next 2Y-6.25%
EPS Next 3Y4.87%
EPS Next 5Y12.92%
Revenue 1Y (TTM)-3.76%
Revenue growth 3Y-1.26%
Revenue growth 5Y0.98%
Sales Q2Q%-9.9%
Revenue Next Year-8.12%
Revenue Next 2Y-3.22%
Revenue Next 3Y-0.75%
Revenue Next 5Y2.11%
EBIT growth 1Y4.54%
EBIT growth 3Y-19.77%
EBIT growth 5Y-9.83%
EBIT Next Year30.7%
EBIT Next 3Y19.8%
EBIT Next 5Y16.56%
FCF growth 1Y-9.37%
FCF growth 3Y-21.63%
FCF growth 5Y-4.06%
OCF growth 1Y-25.29%
OCF growth 3Y-13.38%
OCF growth 5Y-1.28%